GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharming Group (NAS:PHAR) » Definitions » Shiller PE Ratio

Pharming Group (Pharming Group) Shiller PE Ratio : (As of May. 13, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Pharming Group Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Pharming Group Shiller PE Ratio Historical Data

The historical data trend for Pharming Group's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharming Group Shiller PE Ratio Chart

Pharming Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Pharming Group Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Pharming Group's Shiller PE Ratio

For the Biotechnology subindustry, Pharming Group's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharming Group's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharming Group's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Pharming Group's Shiller PE Ratio falls into.



Pharming Group Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Pharming Group's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Pharming Group's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.05/126.4000*126.4000
=-0.050

Current CPI (Dec. 2023) = 126.4000.

Pharming Group Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -600.633 99.390 -763.860
201406 -0.051 99.240 -0.065
201409 0.005 99.960 0.006
201412 0.398 99.050 0.508
201503 -0.032 99.750 -0.041
201506 -0.068 100.230 -0.086
201509 -0.066 100.500 -0.083
201512 -0.106 99.730 -0.134
201603 -0.091 100.310 -0.115
201606 -0.088 100.260 -0.111
201609 -0.102 100.570 -0.128
201612 -0.161 100.710 -0.202
201703 -0.128 101.440 -0.159
201706 -0.598 101.370 -0.746
201709 -0.201 102.030 -0.249
201712 -0.919 101.970 -1.139
201803 0.099 102.470 0.122
201806 0.051 103.100 0.063
201809 0.094 103.950 0.114
201812 0.191 103.970 0.232
201903 0.112 105.370 0.134
201906 0.115 105.840 0.137
201909 0.166 106.700 0.197
201912 0.216 106.800 0.256
202003 0.121 106.850 0.143
202006 0.160 107.510 0.188
202009 0.130 107.880 0.152
202012 0.110 107.850 0.129
202103 0.130 108.870 0.151
202106 0.060 109.670 0.069
202109 -0.010 110.790 -0.011
202112 0.030 114.010 0.033
202203 0.050 119.460 0.053
202206 0.220 119.050 0.234
202209 0.130 126.890 0.129
202212 -0.220 124.940 -0.223
202303 -0.190 124.720 -0.193
202306 0.020 125.830 0.020
202309 0.060 127.160 0.060
202312 -0.050 126.400 -0.050

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Pharming Group  (NAS:PHAR) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Pharming Group Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Pharming Group's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharming Group (Pharming Group) Business Description

Address
Darwinweg 24, Leiden, ZH, NLD, 2333 CR
Pharming Group is engaged in the development of products for the treatment of unmet medical needs. The company focuses on developing and producing human therapeutic proteins to provide life-changing solutions to patients. Its product includes Ruconest. The revenue is generated from the United States.

Pharming Group (Pharming Group) Headlines

From GuruFocus